Clinical Trial Update: A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a Japanese encephalitis chimeric virus vaccine to the SA14-14-2 vaccine in infants and toddlers has completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis chimeric virus vaccine
• SA14-14-2 vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Encephalitis, Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-02